SUPERNUS PHARMACEUTICALS, INC. (SUPN) › Net IncomeSUPERNUS PHARMACEUTICALS, INC. (SUPN) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$38.46M2011: $53.81M2012: -$46.28M2013: -$92.27M2014: -$10.93M2015: $13.94M2016: $91.22M2017: $57.28M2018: $110.99M2019: $113.06M2020: $126.95M2021: $53.42M2022: $60.71M2023: $1.32M2024: $73.86M2025: -$38.55M-$38.55M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$38.55M-152.2%2024$73.86M+5512.8%2023$1.32M-97.8%2022$60.71M+13.6%2021$53.42M-57.9%2020$126.95M+12.3%2019$113.06M+1.9%2018$110.99M+93.8%2017$57.28M-37.2%2016$91.22M+554.2%2015$13.94M+227.6%2014-$10.93M+88.2%2013-$92.27M-99.4%2012-$46.28M-186.0%2011$53.81M+239.9%2010-$38.46M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share